Edgewell Personal Care Financials - Benzinga

Edgewell Personal Care Co

EPCNYSE

Trade with Public

Trade with Public

$28.09

0.772.8%

最終更新: Sep 25, 2:08 PM

概要ニュース業績予想イベント目標株価財務センチメント株主構成配当比較オプション株式レポート

Edgewell Personal Care Financials

Edgewell Personal Care (EPC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Edgewell Personal Care Q3 Adj. EPS $0.72 Beats $0.62 Estimate, Sales $570.100M Miss $576.471M Estimate

Edgewell Personal Care (NYSE:EPC) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.62 by 16.13 percent. This is a 21.74 percent decrease over earnings of $0.92 per share

Benzinga Newsdesk

PRO
Edgewell Personal Care Narrows FY2026 GAAP EPS Guidance from $0.00-$0.40 to $0.00-$0.20 vs $0.15 Est

Edgewell Personal Care (NYSE:EPC) narrows FY2026 GAAP EPS guidance from $0.00-$0.40 to $0.00-$0.20 vs $0.15 analyst estimate..

Benzinga Newsdesk

PRO
Edgewell Personal Care Narrows FY2026 Adj EPS Guidance from $1.70-$2.10 to $1.80-$2.00 vs $1.90 Est; Narrows FY2026 Sales Guidance from $2.242B-$2.309B to $2.253B-$2.264B vs $1.999B Est

Edgewell Personal Care (NYSE:EPC) narrows FY2026 Adj EPS guidance from $1.70-$2.10 to $1.80-$2.00 vs $1.90 analyst estimate. Narrows FY2026 sales outlook from $2.242 billion-$2.309 billion to $2.253 billion-$2.264

Benzinga Newsdesk

Earnings Scheduled For May 6, 2026

Benzinga Insights

PRO
Edgewell Personal Care Affirms FY2026 Adj EPS Guidance of $1.70-$2.10 vs $1.92 Est

Edgewell Personal Care (NYSE:EPC) affirms FY2026 Adj EPS guidance from $1.70-$2.10 to $1.70-$2.10 vs $1.92 analyst estimate..

Benzinga Newsdesk

PRO
Edgewell Personal Care Q2 Adj. EPS $0.60 Beats $0.45 Estimate, Sales $519.500M Beat $515.046M Estimate

Edgewell Personal Care (NYSE:EPC) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.45 by 33.33 percent. This is a 31.03 percent decrease over earnings of $0.87 per share from

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved